Assignee
NEUVIVO INC
US·10 granted patents·3 pending applications·20 citations·filing 2022–2025
Top patents by PatentIndex Score
13 records- 0196US11938150B2Treatment of neurodegenerative disease with sodium chloriteNEUVIVO INC·Filed 2023·Granted Mar 26, 2024·4 cites·20 claims
- 0296US11938149B2Treatment of neurodegenerative disease with sodium chloriteNEUVIVO INC·Filed 2023·Granted Mar 26, 2024·4 cites·20 claims
- 0396US11938147B2Treatment of neurodegenerative disease with sodium chloriteNEUVIVO INC·Filed 2022·Granted Mar 26, 2024·4 cites·14 claims
- 0496US11938148B2Treatment of neurodegenerative disease with sodium chloriteNEUVIVO INC·Filed 2023·Granted Mar 26, 2024·4 cites·14 claims
- 0593US12109230B2Treatment of neurodegenerative disease with sodium chloriteNEUVIVO INC·Filed 2024·Granted Oct 8, 2024·1 cites·20 claims
- 0693US12109228B2Treatment of neurodegenerative disease with sodium chloriteNEUVIVO INC·Filed 2024·Granted Oct 8, 2024·1 cites·14 claims
- 0793US12109229B2Treatment of neurodegenerative disease with sodium chloriteNEUVIVO INC·Filed 2024·Granted Oct 8, 2024·1 cites·14 claims
- 0893US12109231B2Treatment of neurodegenerative disease with sodium chloriteNEUVIVO INC·Filed 2024·Granted Oct 8, 2024·1 cites·20 claims
- 0988US2025114397A1Treatment of neurodegenerative disease with sodium chloriteNEUVIVO INC·Filed 2024·Application pending·0 cites
- 1077US2025144135A1Treatment of neurodegenerative disease with sodium chloriteNEUVIVO INC·Filed 2025·Application pending·0 cites
- 1169US2024367988A1Chlorite compositionsNEUVIVO INC·Filed 2024·Application pending·0 cites
- 1268US12233086B2Biomarkers for neurogenerative diseaseNEUVIVO INC·Filed 2023·Granted Feb 25, 2025·0 cites·18 claims
- 1359US12329776B2Treatment methods for ALS patientsNEUVIVO INC·Filed 2023·Granted Jun 17, 2025·0 cites·11 claims
Join the waitlist — get patent alerts
Get an alert when NEUVIVO INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →